ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the year and the fourth quarter ended December 31, 2014.
“During 2015, we plan to advance the clinical development of our product candidates principally in the following ways” The Company reported a net loss of $23,391,000 or $0.37 per share, for the year ended December 31, 2014, compared with a net loss of $24,600,000 or $0.39 per share, for the year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
